AMEX · Biotechnology

ARMP (ARMP) Stock

$5.28 -4.17% AMEX: ARMP Healthcare

Valuation

MetricValue
Price$5.28
Market Cap$193.83M
P/E Ratio-1.03
P/B Ratio-0.87
P/S Ratio60.65
EPS (TTM)$0.00
52-Week High$16.34
52-Week Low$2.40
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE89.70%
ROA-213.65%
ROCE25.40%
Gross Margin-620.00%
Operating Margin-620.00%
Net Margin-95.54%
Debt/Equity-1.36
Current Ratio1.22

Annual Financials (USD)

Metric20212022202320242025
Revenue$4.0M$6.0M$5.0M$5.0M$5.0M
Operating Profit$-24.0M$-37.0M$-41.0M$-42.0M$-31.0M
Net Profit$-23.0M$-37.0M$-69.0M$-19.0M$-174.0M
EPS$-0.96$-1.08$-1.91$-0.52$-4.80
Op Margin-532.5%-670.8%-902.9%-820.2%-636.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$70.0M$108.0M$98.0M$86.0M$77.0M
Total Liabilities$44.0M$72.0M$130.0M$134.0M$295.0M
Cash$10.0M$15.0M$14.0M$9.0M$9.0M
Borrowings$38.0M$49.0M$120.0M$127.0M$288.0M

Latest News

Armata Pharma Reaches FDA Agreement on Pediatric Study Plan for AP-SA02 MT Newswires · Jul 13, 2026 Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia PR Newswire · Jul 13, 2026 Sector Update: Healthcare Stocks Mixed Pre-Bell Tuesday MT Newswires · Jun 23, 2026 Armata Pharmaceuticals Receives Additional $2.5 Million in Funding From US Department of Defense MT Newswires · Jun 23, 2026 Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02 PR Newswire · Jun 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-24.0M$-32.0M$-47.0M$-38.0M$-26.0M
Investing Cash Flow$-3.0M$-4.0M$-16.0M$-4.0M$-1.0M
Financing Cash Flow$-1.0M$0$0$0$0
Net Cash Flow$1.0M$5.0M$-2.0M$-4.0M$-1.0M
Free Cash Flow$-25.0M$-35.0M$-56.0M$-39.0M$-26.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.01
EV / EBITDA-2.90
FCF Yield-12.89%
Quick Ratio0.11
Interest Coverage-1.90
Return 1Y71.18%
Return 3Y216.13%
Return 5Y3.16%

Ownership

Insiders Held68.55%
Institutions Held10.46%
Institutions Float Held33.25%
Institutional HolderSharesReport Date
Madison Asset Management, LLC2,107,6752026-03-31
Vanguard Capital Management LLC366,0282026-03-31
Millennium Management Llc257,9922026-03-31
683 Capital Management LLC137,0002026-03-31
Geode Capital Management, LLC114,5552026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CCCC $3.87 +4.31% -2.54 $427.89M 0.00%
CDXS $1.51 -11.18% -5.06 $162.42M 0.00%
GNFTGenfit S.A. $8.95 +4.07% 261.07 $445.68M 0.00%
IMDX $3.84 -2.04% -2.83 $123.99M 0.00%
IPHAInnate Pharma S.A. $1.79 +0.14% -2.89 $168.32M 0.00%

About ARMP

ARMP is led by CEO Deborah L. Birx, employs 60 people, headquartered in US, publicly traded since 1994.

ARMP stock trades at $5.28 with a market capitalization of $193.83M. The stock is valued at a price-to-earnings (P/E) ratio of -1.03, price-to-book of -0.87, price-to-sales of 60.65. Over the past 52 weeks the stock has ranged between $2.40 and $16.34, and currently trades 67.7% below its 52-week high.

On profitability, ARMP generates a return on equity (ROE) of 89.70% — well above the market average, a sign of a high-quality business, return on capital employed of 25.40%, an operating margin of -620.00%, a net profit margin of -95.54%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides